Honokiol showed to be highly effective in dose-and time-dependently inhibit the viability of LNCaP and C4-2, cutting the protein level of AR, androgen-stimulating nuclear translocation of AR, and transcriptional activity of AR in prostate cancer cells lines [219]. The gene discussed is AR; the disease is prostate carcinoma.